A model for preconceptional prediction of recurrent early-onset preeclampsia: Derivation and internal validation

Reproductive Sciences

Volumn 18, Issue 11, 2011, Pages 1154-1159

  Kuijk, Sander M J Van ^a   Nijdam, Marie Elise ^b   Janssen, Kristel J M ^b   Sep, Simone J S ^a   Peeters, Louis L ^a   Delahaije, Denise H J ^a   Spaanderman, Marc ^a   Bruinse, Hein W ^b   Franx, Arie ^b   Bots, Michiel L ^b   Langenveld, Josje ^a   Post, Joris Van Der ^c   Rijn, Bas B Van ^b,d   Smits, Luc ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

prediction; preeclampsia; recurrence; risk

Indexed keywords

GLUCOSE;

ARTICLE; BODY MASS; DIASTOLIC BLOOD PRESSURE; FEMALE; GESTATION PERIOD; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HELLP SYNDROME; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRENATAL CARE; PRIMIGRAVIDA; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; RISK ASSESSMENT; SMALL FOR DATE INFANT; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

BLOOD GLUCOSE; BODY MASS INDEX; FASTING; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; LOGISTIC MODELS; PRE-ECLAMPSIA; PRECONCEPTION CARE; PREGNANCY; RECURRENCE; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 80055013777     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719111410708     Document Type: Article

References (40)

1. Hernandez-Diaz S, Toh S, Cnattingius S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ. 2009 ; 338: b2255
2. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol. 2000 ; 95 (1). 24-28 (Pubitemid 30001623)
3. Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease?. BJOG. 2004 ; 111 (4). 298-302 (Pubitemid 38446102)
4. Witlin AG, Sibai BM. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol. 1998 ; 92 (5). 883-889 (Pubitemid 28487694)
5. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006 ; 367 (9516). 1066-1074
6. Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA. 2002 ; 287 (24). 3183-3186 (Pubitemid 34686089)
7. van Rijn BB, Hoeks LB, Bots ML, Franx A, Bruinse HW. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol. 2006 ; 195 (3). 723-728 (Pubitemid 44292141)
8. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005 ; 308 (5728). 1592-1594 (Pubitemid 40807500)
9. Dekker GA. Risk factors for preeclampsia. Clin Obstet Gynecol. 1999 ; 42 (3). 422-435 (Pubitemid 30017267)
10. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005 ; 365 (9461). 785-799 (Pubitemid 40311367)
11. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005 ; 330 (7491). 565
12. Wagner LK. Diagnosis and management of preeclampsia. Am Fam Physician. 2004 ; 70 (12). 2317-2324 (Pubitemid 39657180)
13. Hnat MD, Sibai BM, Caritis S, et al. Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol. 2002 ; 186 (3). 422-426 (Pubitemid 34234151)
14. Sep SJ, Smits LJ, Prins MH, Spaanderman ME, Peeters LL. Simple prepregnant prediction rule for recurrent early-onset hypertensive disease in pregnancy. Reprod Sci. 2009 ; 16 (1). 80-87
15. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001 ; 20 (1). IX - XIV
16. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004 ; 103 (5)(Pt 1). 981-991 (Pubitemid 40459001)
17. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol. 2008 ; 112 (2)(Pt 1). 359-372
18. Dildy GA 3rd, Belfort MA, Smulian JC. Preeclampsia recurrence and prevention. Semin Perinatol. 2007 ; 31 (3). 135-141 (Pubitemid 46776863)
19. Rasmussen S, Irgens LM, Albrechtsen S, Dalaker K. Predicting preeclampsia in the second pregnancy from low birth weight in the first pregnancy. Obstet Gynecol. 2000 ; 96 (5). 696-700
20. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996 ; 49 (12). 1373-1379 (Pubitemid 27028925)
21. Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what, why, and how?. BMJ. 2009 ; 338: b375
22. Royston P, Moons KG, Altman DG, Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ. 2009 ; 338: b604
23. O'Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology. 2003 ; 14 (3). 368-374 (Pubitemid 40417091)
24. Montoro MN, Kjos SL, Chandler M, Peters RK, Xiang AH, Buchanan TA. Insulin resistance and preeclampsia in gestational diabetes mellitus. Diabetes Care. 2005 ; 28 (8). 1995-2000 (Pubitemid 41060975)
25. Scioscia M, Gumaa K, Rademacher TW. The link between insulin resistance and preeclampsia: new perspectives. J Reprod Immunol. 2009 ; 82 (2). 100-105
26. The Netherlands Perinatal Registry [homepage on the internet]. Bilthoven: NPR-foundation; [cited 2010 October 1]. http://www.perinatreg.nl/
27. Rubin DB. Inference and missing data. Biometrika. 1976 ; 63 (3). 581-592
28. Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006 ; 59 (10). 1087-1091 (Pubitemid 44374314)
29. Frank E, Harrell J Regression Modeling Strategies. New York, NY: Springer ; 2001 :
30. Steyerberg EW Clinical Prediction Models. New York, NY: Springer ; 2009 :
31. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983 ; 148 (3). 839-843 (Pubitemid 13033817)
32. Hosmer DW, Lemeshow S Applied Logistic Regression. New York, NY: John Wiley ; 2000 :
33. Steyerberg EW, Harrell FE, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001 ; 54 (8). 774-781 (Pubitemid 32722180)
34. Harrell FE Regression Modeling Strategies. New York, NY: Springer ; 2001 :
35. Greenland S. Quantifying biases in causal models: classical confounding vs collider-stratification bias. Epidemiology. 2003 ; 14 (3). 300-306 (Pubitemid 40417081)
36. SmitsLJVan KuijkSMJPeetersLLPrinsMHSepSJ. Collider-stratification bias complicates estimation of the strength of risk factors of disease recurrence. Submitted.
37. Steyerberg EW Clinical Prediction Models. New York, NY: Springer ; 2009 :
38. Facchinetti F, Marozio L, Frusca T, et al. Maternal thrombophilia and the risk of recurrence of preeclampsia. Am J Obstet Gynecol. 2009 ; 200 (1). 46. e41 - e45
39. Aardenburg R, Spaanderman ME, van Eijndhoven HW, de Leeuw PW, Peeters LL. A low plasma volume in formerly preeclamptic women predisposes to the recurrence of hypertensive complications in the next pregnancy. J Soc Gynecol Investig. 2006 ; 13 (8). 598-603 (Pubitemid 44908986)
40. Delahaije DH, van Kuijk SM, Dirksen CD, et al. Cost-effectiveness of recurrence risk guided care versus care as usual in women who suffered from early-onset preeclampsia including HELLP syndrome in their previous pregnancy (the PreCare study). BMC Pregnancy Childbirth. 2010 ; 10: 60